BSE filing, NSE: DOLPHMED. Summary written from the filing by ALFA Finder's alert engine.
Dolphin Medical Services Ltd: key numbers
- Share price
- ₹6.78
- Market cap
- ₹10.24 Cr
- Revenue (annual)
- ₹0.75 Cr
- Net profit (annual)
- ₹0.04 Cr
- P/E (TTM)
- 214.6×Sector 52.0×
- Promoter holding
- 100.00%+73.56% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dolphin Medical Services Ltd
All →Dolphin Medical Services Management Change
Dolphin Medical Services appointed Mr. Kotha as Chairman and Promoter Director, reclassifying Mr. Mallour to Promoter Director. The board also reconstituted its committees.
Dolphin Medical Services Board Meeting Date
Dolphin Medical Services scheduled a board meeting for September 21, 2026. The agenda includes board appointments, committee reconstitution, and promoter reclassification.
Dolphin Medical Services Board Meeting Outcome
Dolphin Medical Services Limited announced the immediate resignation of its Managing Director and CEO, Mr. G V Mohan Prasad, and two other directors.
Dolphin Medical Services Annual General Meeting
Dolphin Medical Services Ltd received Registrar of Companies approval to extend its Annual General Meeting deadline by two months. The meeting is now scheduled for November 30, 2026.
- Execution
- 2 months extension
Dolphin Medical Services Open Offer: ₹0.01 Cr
Acquirers Amarandhar Reddy Kotha and Mallour Rajesh Kumar completed an open offer for Dolphin Medical Services Limited. They acquired 18,000 shares at ₹4.80 each, totaling ₹0.01 Crore.
- Value
- ₹0.01 Cr
Dolphin Medical Services Q1 FY27 Results: Net Profit ₹0 Cr
Dolphin Medical Services Ltd reported revenue from operations of ₹0.2 Cr (+0.0% YoY) and net profit of ₹0 Cr for Q1 FY27.
- Key figure
- Net profit ₹0 Cr
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.